HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gunhild Keller Selected Research
Gunhild Keller Research Topics
Disease
17
Neoplasms (Cancer)
01/2013 - 03/2005
5
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2013 - 04/2008
4
Melanoma (Melanoma, Malignant)
07/2008 - 07/2005
4
Endometrial Neoplasms (Endometrial Cancer)
09/2005 - 04/2005
3
Blast Crisis (Blast Phase)
09/2009 - 04/2008
3
Breast Neoplasms (Breast Cancer)
07/2006 - 09/2005
3
Lymphoma (Lymphomas)
09/2005 - 05/2005
2
Neoplasm Metastasis (Metastasis)
09/2012 - 07/2005
2
Aneuploidy (Aneuploid)
09/2012 - 09/2009
2
Philadelphia Chromosome
05/2011 - 10/2009
2
Leukemia
12/2008 - 04/2008
2
Ovarian Neoplasms (Ovarian Cancer)
07/2006 - 03/2005
2
Carcinoma (Carcinomatosis)
12/2005 - 03/2005
2
Renal Cell Carcinoma (Grawitz Tumor)
11/2005 - 08/2005
2
Body Weight (Weight, Body)
05/2005 - 04/2005
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2012
1
Urinary Bladder Neoplasms (Bladder Cancer)
07/2012
1
Pulmonary Hypertension
05/2011
1
Hepatocellular Carcinoma (Hepatoma)
09/2009
1
Disease Progression
09/2009
Drug/Important Bio-Agent (IBA)
7
Proteins (Proteins, Gene)
FDA Link
07/2006 - 04/2005
7
AN 204 (AN 201)
IBA
07/2006 - 05/2005
7
Messenger RNA (mRNA)
IBA
07/2006 - 04/2005
6
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
07/2012 - 04/2005
5
LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)
IBA
07/2012 - 04/2005
5
AN 215
IBA
07/2006 - 03/2005
5
Bombesin
IBA
07/2006 - 03/2005
5
AN 207
IBA
07/2006 - 04/2005
4
Imatinib Mesylate (Gleevec)
FDA Link
04/2011 - 04/2008
4
AN 238
IBA
07/2006 - 05/2005
4
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
07/2006 - 05/2005
3
Tyrosine Kinase Inhibitors
IBA
01/2013 - 10/2009
3
danusertib
IBA
09/2012 - 04/2008
3
Aurora Kinases
IBA
09/2012 - 12/2008
3
Doxorubicin (Adriamycin)
FDA Link
Generic
07/2012 - 05/2005
2
lysine(6)-doxorubicin LHRH
IBA
07/2012 - 04/2005
2
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
07/2006 - 11/2005
2
RC 121
IBA
06/2006 - 05/2005
2
Somatostatin Receptors (Somatostatin Receptor)
IBA
06/2006 - 05/2005
2
Gastrin-Releasing Peptide
IBA
12/2005 - 03/2005
2
Membrane Transport Proteins (Biological Pump)
IBA
11/2005 - 09/2005
2
somatotropin releasing hormone receptor
IBA
07/2005 - 06/2005
2
Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)
IBA
07/2005 - 06/2005
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2005 - 06/2005
1
Proteome
IBA
01/2013
1
Streptozocin (Streptozotocin)
FDA Link
09/2012
1
Fluorouracil (Carac)
FDA Link
Generic
09/2012
1
Dasatinib (BMS 354825)
FDA Link
05/2011
1
Phosphotransferases (Kinase)
IBA
10/2009
1
bosutinib
IBA
10/2009
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
09/2009
1
Histones (Histone)
IBA
09/2009
1
Sorafenib (BAY 43-9006)
FDA Link
09/2009
1
bcr-abl Fusion Proteins
IBA
12/2008
1
PHA 680626
IBA
12/2008
1
N 30
IBA
07/2008
1
RNA (Ribonucleic Acid)
IBA
07/2008
1
Chemokines
IBA
05/2008
1
DNA (Deoxyribonucleic Acid)
IBA
05/2008
1
Peptides (Polypeptides)
IBA
07/2006
1
Glycoproteins (Glycoprotein)
IBA
09/2005
1
Subfamily B ATP Binding Cassette Transporter
IBA
08/2005
1
Triptorelin Pamoate (Trelstar)
FDA Link
08/2005
1
Insulin-Like Growth Factor I (IGF-1)
IBA
07/2005
1
MZ-J-7-138
IBA
07/2005
1
MZ 5-156
IBA
07/2005
1
MZ-J-7-118
IBA
06/2005
1
Insulin-Like Growth Factor II (Somatomedin A)
IBA
06/2005
1
Ligands
IBA
06/2005
Therapy/Procedure
14
Therapeutics
01/2013 - 06/2005
9
Drug Therapy (Chemotherapy)
06/2006 - 03/2005
2
Aftercare (After-Treatment)
07/2006 - 12/2005
1
Cell Transplantation
09/2012
1
Conservative Treatment
09/2012
1
Immunotherapy
05/2008
1
Investigational Therapies (Experimental Therapy)
08/2005